Purinergic ionotropic P2X receptors are a family of cation-permeable channels that bind extracellular adenosine 5k-triphosphate. In particular, convergent lines of evidence have recently highlighted P2X 4 receptors as a potentially critical target in the regulation of multiple nervous and behavioural functions, including pain, neuroendocrine regulation and hippocampal plasticity. Nevertheless, the role of the P2X 4 receptor in behavioural organization remains poorly investigated. To study the effects of P2X 4 activation, we tested the acute effects of its potent positive allosteric modulator ivermectin (IVM, 2.5-10 mg/kg i.p.) on a broad set of paradigms capturing complementary aspects of perceptual, emotional and cognitive regulation in mice. In a novel open field, IVM did not induce significant changes in locomotor activity, but increased the time spent in the peripheral zone. In contrast, IVM produced anxiolytic-like effects in the elevated plus maze and marble burying tasks, as well as depression-like behaviours in the tail-suspension and forced swim tests. The agent induced no significant behavioural changes in the conditioned place preference test and in the novel object recognition task. Finally, the drug induced a dose-dependent decrease in sensorimotor gating, as assessed by pre-pulse inhibition (PPI) of the acoustic startle reflex. In P2X 4 knockout mice, the effects of IVM in the open field and elevated plus maze were similar to those observed in wild type mice ; conversely, the drug significantly increased startle amplitude and failed to reduce PPI. Taken together, these results suggest that P2X 4 receptors may play a role in the regulation of sensorimotor gating.
Introduction
Purinergic ionotropic P2X receptors are a family of hetero-and homotrimeric cation-permeable channels that bind extracellular adenosine 5k-triphosphate (North, 2002) . The biophysical and pharmacological properties of P2X receptors are defined by their subunit composition (Khakh & North, 2006) . In particular, of the seven P2X subunits characterized to date (termed P2X1 to P2X7), recent evidence has highlighted P2X 4 subunits as a potentially interesting target in the regulation of nervous functions. P2X 4 subunits form homotrimeric receptors with distinct functional properties (Bo et al. 1995 ; Soto et al. 1996) , as well as heteromers with other P2X subunits (Guo et al. 2007 ; Nicke et al. 2005 ; Ormond et al. 2006 ; for contrasting results, see Antonio et al. 2011) . P2X 4 receptors are abundant in the central nervous system (Rubio & Soto, 2001 ; Tsuda et al. 2003) and involved in the regulation of neuropathic pain (Tsuda et al. 2003 ; Ulmann et al. 2008 ; Zhang et al. 2006) , neuroendocrine regulation (Zemkova et al. 2010 ) and hippocampal plasticity (Baxter et al. 2011 ; Lorca et al. 2011 ; Sim et al. 2006 ). Furthermore, P2X 4 receptors have been recently shown to modulate the activity of c-amino-butyric acid (GABA) A (Jo et al. 2011 ) and N-methyl-D-aspartate glutamate (Baxter et al. 2011) receptors. Recent studies have documented that some antidepressants may inhibit P2X 4 receptors (Nagata et al. 2009 ), although this evidence remains controversial in view of contrasting findings (Sim & North, 2010 ; Toulme et al. 2010a ). Furthermore, converging lines of in vitro and in vivo evidence suggest that P2X 4 receptors may be an important therapeutic target for alcohol use disorders (Asatryan et al. , 2011 Kimpel et al. 2007 ; Popova et al. 2010 ; Tabakoff et al. 2009 ).
In contrast with this background, the pharmacological armamentarium to probe P2X 4 receptors is very limited. P2X 4 receptors are poorly sensitive to P2X receptor antagonists, such as suramin and pyridoxal phosphate-6azo-(benzene-2,4-disulfonic acid) (Buell et al. 1996) . Conversely, research has shown that the anti-parasitic ivermectin (IVM) acts as a potent positive allosteric regulator of P2X 4 in either its homomeric or heteromeric configurations, but does not interact with other P2X receptors (Khakh et al. 1999 ; Priel & Silberberg, 2004) . IVM is a mixture of semi-synthetic macrocyclic lactone disaccharides derived by hydroxylation of avermectins B 1a and B 1b , natural fermentation products of the actinomycete Streptomyces avermitilis. IVM is widely adopted in human and veterinarian medicine as a broad-spectrum anthelmintic and insecticide agent (Geary, 2005 ; Richard-Lenoble et al. 2003) , with high therapeutic index and limited side-effects. The anti-parasitic mechanism of IVM is based on the activation of glutamate-gated chloride channels specific to invertebrates (Cully et al. 1994 ; Vassilatis et al. 1997) .
In mammalians, in addition to its action on P2X 4 receptors, IVM has been shown to activate GABA A receptors and exert weak effects on the positive modulation of other ionotropic channels, including glycine, and acetylcholine nicotinic receptors (Collins & Millar, 2010 ; Dawson et al. 2000 ; Krause et al. 1998 ; Sattelle et al. 2009 ; Shan et al. 2001 ; Sung et al. 2009 ).
Previous studies have revealed that long-term administration of IVM has subtle behavioural effects on locomotor and sensory reactivity of mice (Davis et al. 1999) ; furthermore, this substance has been shown to exert anxiolytic-like properties in rats (de Spinosa et al. 2002) . Capitalizing on our discovery that IVM antagonizes ethanol-mediated inhibition of P2X 4 receptors , we recently found that this compound reduces alcohol consumption (Yardley et al. 2012) . Nevertheless, to the best of our knowledge, the acute behavioural effects of IVM have not been the object of systematic investigations. Thus, in consideration of the potential role of P2X 4 receptors in the regulation of brain functions, we addressed the present study to determine the perceptual, emotional and cognitive impact of IVM in C57BL/6 mice, using a broad spectrum of well-validated paradigms targeting complementary aspects of behavioural regulation.
Materials and method

Animals
Studies were performed on drug-naive, C57BL/6J (Jackson Laboratory, USA) wild-type (WT) and P2X 4 knockout (KO) male mice, aged 6-10 wk at the time of testing. P2X 4 KO mice were generated and genotyped according to previous protocols (Sim et al. 2006) . Animals were acclimatized to the housing facility for a minimum of 1 wk and group-housed (four mice per cage) in polycarbonate cages, with ad libitum access to food and water.
The holding room was maintained at approximately 22 xC with a 12 : 12 h light :dark cycle (lights on 06 : 00 hours). All procedures were in compliance with the National Institute of Health guidelines and the protocols were approved by the University of Southern California Institutional Animal Care and Use Committee.
Generation and identification of KO P2X 4
x/x mice Drugs IVM (Norbrook Inc., USA) and its vehicle propylene glycol (Alfa Aesar, USA) were diluted in a 0.9 % saline solution, to a concentration that would allow for an injection volume of 0.01 ml/g body weight. Throughout all experiments, IVM was injected 8 h before behavioural testing, as our previous studies documented that the maximal efficacy and the T max of the drug in brain and plasma was reached at this time (Yardley et al. 2012) .
Preliminary physical assessment
The impact of IVM in mice was tested on posture, gait, heart rate, breathing frequency and neurological reflexes (righting reflex, postural reflex, eye-blink reflex and whisker-orienting reflex ; Davis et al. 1999) .
Sticky tape test
Mice were briefly restrained and a circular piece of tape was placed on the bottom of each forepaw. Mice were then released and the latency to remove the first piece of tape was recorded.
Hot plate
Mice were individually exposed to a hot plate (IITC Life Science, USA) at 47.5 and 50 xC and the latency to lick their paws was measured. We used a cut-off time of 40 s to eliminate any potential tissue damage.
Novel open field
The open field was a Plexiglas square grey arena (40r40 cm) surrounded by four black walls (40 cm high).
On the floor, two concentric zones of equivalent areas were defined : a central square quadrant and a peripheral frame directly adjacent to the walls. Mice were placed in the centre and their behaviour was monitored for 5 min.
Analysis of locomotor activity was performed using Ethovision (Noldus Instruments, The Netherlands). Behavioural measures included the distance travelled, duration in the central zone, percent activity in the centre (defined as the distance travelled in the centre divided by the total distance travelled), meandering (defined as the ratio of the turn-angle degrees over total distance ; Kalueff et al. 2007 ), number of rearing episodes and percent time moving (calculated as the time spent moving over the total time).
Elevated plus maze
Behaviour in the elevated plus maze was monitored as described elsewhere (Bortolato et al. 2009 ). The apparatus was black Plexiglas with a light grey floor and consisted of two open (25r5 cm) and two closed (25r5r5 cm) arms, which extended from a central platform (5r5 cm) at 60 cm from the ground. Mice were individually placed on the central platform facing an open arm and their behaviour was observed for 5 min by an experimenter unaware of the genotype. An arm entry was counted when all four paws were inside the arm. Behavioural measures included time spent and entries into each partition of the elevated plus maze, number of head dips, stretch-attend postures (both defined as in Rodgers et al. 1992 ) and rears.
Marble burying
Marble burying was tested as previously described (Bortolato et al. 2009 ). Briefly, mice were acclimatized for 10 min to novel cages (35r28 cm) filled with sawdust. At the end of this phase, they were briefly removed and 20 glass marbles were placed on the surface of the cage at even distances. Animals were then reintroduced into the cages and their behaviour was monitored for the following 10 min. The number of marbles buried, as well as the frequency and overall duration of digging was scored. A marble was considered buried if at least two-thirds of its surface area was covered in sawdust.
Forced swim test
The forced swim test was performed as previously described (Gobbi et al. 2005) . Briefly, mice were habituated to clear Plexiglas cylinders (40 cmr19 cm in diameter) filled to 15 cm with water for 1 min. The water temperature was maintained at 30 xC. On the following day, mice were re-exposed to the cylinder using the abovementioned conditions for 5 min. Environmental light was kept at 300 lux. Animals were video-recorded and the duration of immobility (s) and the latency to immobility (s) were measured.
Tail suspension test
The tail suspension test was performed as described elsewhere (Scott et al. 2008) . Mice were individually suspended by the tail using medical tape affixed to a hook, at 30 cm from the floor. Environmental light was kept at 300 lux. Animals were video-recorded for 6 min and the duration of immobility (s), the latency to immobility (s) and number of faecal boli were measured.
Conditioned place preference (CPP)
CPP was evaluated as previously described (Bortolato et al. 2006 ; Maldonado et al. 1997) . The apparatus consisted of two different compartments (15r15r15 cm) separated by a central neutral area (start compartment), through two guillotine doors. The two compartments featured different visual cues (striped or triangular patterns) on the walls and tactile cues (square or chequered grid) on the floor. The combinations of visual and tactile cues were present in the compartments in a counterbalanced order. The experiment was conducted with a biased design and consisted of three consecutive phases. In phase I (pre-conditioning), the animals were habituated to the apparatus for 2 d and their initial side preferences were recorded in a 15-min trial. Phase II (training) lasted 10 d. On odd days, mice received IVM or vehicle and were placed in the non-preferred (NP) compartment (with the guillotine door closed) for 15 min ; conversely, on even days, mice received vehicle and were placed in the preferred compartment for 15 min. On the test day (post-conditioning, phase III), the animals were given no treatment and were placed in the start compartment, with free access to both sides for 15 min. IVM preference was measured as the difference between the time spent in the drug-paired compartment (NP) during the post-conditioning and pre-conditioning phases.
Acoustic startle and pre-pulse inhibition (PPI) of the startle reflex
Acoustic startle reflex and PPI were tested as previously described . The apparatus used for detection of startle reflex (San Diego Instruments, USA) consisted of one standard cage placed in soundattenuated chambers with fan ventilation. Each cage consisted of a Plexiglas cylinder of 3 cm diameter, mounted on a piezoelectric accelerometric platform connected to an analogue-digital converter. Background noise and acoustic bursts were conveyed by two separate speakers, each one properly placed so as to produce a variation of sound within 1 dB across the startle cage. Both speakers and startle cages were connected to a main PC, which detected and analysed all chamber variables with specific software. Before each testing session, acoustic stimuli were calibrated via specific devices supplied by San Diego Instruments. Mice were placed in a cage for a 5-min acclimatization period with a 70 dB white noise background, which continued for the remainder of the session. Each session consisted of three consecutive sequences of trials (periods). Unlike the first and the third period -during which mice were presented with only five pulse-alone trials of 115 dB -the second period consisted of a pseudorandom sequence of 40 trials, including 12 pulse-alone trials, 30 trials of pulse preceded by 73, 76 and 82 dB pre-pulses (respectively defined as PP3, PP6 and PP12 ; 10 for each level of prepulse loudness) and eight no stimulus trials, where only the background noise was delivered. The duration of pulses and pre-pulses was 80 and 40 ms, respectively. Pre-pulse-pulse delay amounted to 100 ms. Inter-trial intervals were selected randomly between 10 and 15 s. Percent PPI was calculated using the following formula : 100-[(mean startle amplitude for pre-pulse pulse trials/ mean startle amplitude for pulse alone trials)r100].
Novel object exploration and recognition
We used a modified version of the protocol described in Bortolato et al. (2010) . Mice were individually acclimatized to Makrolon cages for 15 min each. The day after, animals were exposed to two novel black plastic cylinders (8 cm tallr3.5 cm in diameter), affixed to the floor and symmetrically placed at 6 cm from the two nearest walls. Mice were placed in a corner, facing the centre and at equal distance from the two objects. Their start position was rotated and counterbalanced for each treatment throughout the test. Twenty-four hours later, mice were placed in the same cage for long-term memory testing. One of the cylinders was replaced by a novel plastic rectangular block (6 cm tallr3r3 cm), which was placed in a counterbalanced fashion to avoid experimental bias. Behaviours for both sessions were videotaped for 15 min. Analysis included the number and total duration of exploratory approaches between novel and familiar objects. Exploration was defined as sniffing or touching either of the two objects with the snout ; sitting on the object was not considered exploration. In the second exploration trial, an object exploration index was calculated as the ratio of the duration of the exploratory approaches targeting the novel objects over the time of exploration of both objects. The locomotor activity was defined as the number of crossings on a grid superimposed onto the image of each cage in a video monitor.
Statistical analyses
Normality and homoscedasticity of data distribution were verified using the Kolmogorov-Smirnov and Bartlett's test. Parametric analyses were performed with one-way analyses of variance (for repeated measures or independent factors, as appropriate), followed by Tukey's test with Spjøtvoll-Stoline correction for post-hoc comparisons. Non-parametric comparisons were carried out by Kruskal-Wallis test, followed by Nemenyi's test for post-hoc comparisons. Significance threshold was set at p=0.05.
Results
Sensorimotor functions, tactile sensitivity and thermal nociception
In an initial set of experiments, we ascertained that IVM did not exert any significant effect on reflex and homecage activity (data not shown). We then studied the ability of IVM to modify haptic perception and somatosensory coordination in the sticky tape test. The P2X 4 positive allosteric modulator did not significantly affect the latency to remove the tape from the forepaws of the mice (F 2,15 =0.02, n.s. ; Fig. 1a ). Furthermore, in consideration of the role of P2X in pain modulation (Toulme et al. 2010b) , we tested its effects on acute thermal nociception in the hot-plate test. However, IVM did not modify the latency to the first paw-licking episode in mice, at either 47.5 xC (F 2,17 =1.51, n.s. ; Fig. 1b ) or 50 xC (F 2,17 =1.69, n.s. ; Fig. 1c ).
Novel open field
We evaluated the effects of IVM in the regulation of the locomotor and exploratory responses within a novel open field. While IVM did not induce significant variations of locomotor activity (F 2,15 =2.12, n.s. ; Fig. 2a ), it dosedependently reduced the time spent in the centre (F 2,15 =8.29, p<0.01 ; Fig. 2b ), as well as the percent locomotor activity in the centre (F 2,15 =6.46, p<0.01 ; Fig. 2c ). In contrast, no differences were detected between treatment groups in meandering (F 2,15 =2.50, n.s. ; Fig. 2d ), number of rears (F 2,15 =1.80, n.s. ; Fig. 2e ) or the percentage of time spent moving (F 2,15 =2.04, n.s. ; Fig. 2f ).
Collectively, these data indicate that IVM enhanced the thigmotactic responses evoked in mice by a novel open arena in mice, without modifying their exploratory behaviour.
Elevated plus maze
To further qualify the role of IVM in the regulation of anxiety-like responses, we tested a separate group of mice in the elevated plus maze paradigm. The highest IVM dose significantly increased the time spent in open arms (F 2,20 =5.73, p<0.05 ; Fig. 3a ). This effect was accompanied by a significant decrease in the closed arm duration (F 2,20 =8.00, p<0.01 ; Fig. 3b ) and an increase in the time spent on the central platform (F 2,20 =10.17, p<0.01 ; Fig. 3c ). Administration of the highest dosage of IVM also significantly elevated the number of total entries (F 2,20 =10.84, p<0.001 ; Fig. 3d ). Additionally, treatment with the 10 mg/kg dose of IVM resulted in increments of head dips (F 2,20 =5.54, p<0.05 ; Fig. 3e ) and rears (F 2,20 =6.10, p<0.01 ; Fig. 3f ). Conversely, the 2.5 mg/kg dose of IVM did not elicit any significant effect in any of the aforementioned parameters. No significant differences were found in stretch-attend postures (data not shown). Taken together, these data show that the 10 mg/kg dose of IVM increased the exploratory activity and reduced anxiety-like reactions in the elevated plus maze, without exerting significant effects on risk assessment.
Marble burying
In line with the effects of IVM in the elevated plus maze, the highest dose of this agent (10 mg/kg i.p.) elicited a significant decrease in marble-burying activity (F 2,26 =16.04, p<0.001 ; Fig. 4a ). The 10 mg/kg dose also induced a decrease in digging duration (F 2,25 =4.34, p<0.05 ; Fig. 4b ), but not number of digging bouts (F 2,25 =2.35, n.s. ; Fig. 4c ).
Tail suspension
We proceeded with the assessment of IVM's effects on depression-related responses in mice. In the tailsuspension paradigm, the 2.5 mg/kg dose of the drug significantly increased immobility time in comparison to both the vehicle and the 10 mg/kg dose (F 2,18 =11.17 ; Fig. 5a ). No significant difference, however, was found between animals treated with the 10 mg/kg dose and vehicle. IVM did not induce significant changes in latency to immobility (H2, 21=2.14, n.s. ; data not shown).
Forced swim test
In the forced swim paradigm, IVM treatment induced a dose-dependent increase in the duration of immobility (F 2,24 =3.54, p<0.05 ; Fig. 5b ). Post-hoc analyses revealed that this effect was due to the difference between the trend was also detected between the 2.5 mg/kg dose and the vehicle (p<0.10). No significant difference was found between the groups treated with the two IVM doses. Similar to the results in the tail-suspension tests, IVM failed to affect the latency to immobility (F 2,25 =0.10, n.s.).
Conditioned place preference
In the CPP test, IVM did not elicit any overt rewarding or aversive effect, as indicated by the absence of significant changes in preference for the drug-paired compartments (F 2,19 =0.24, n.s. ; Fig. 5c ). No significant differences were found in either locomotor activity during the pre-and post-conditioning phases or in the differences of time spent in the other compartment of the apparatus (data not shown).
PPI of the acoustic startle
Treatment with IVM did not induce significant alterations of acoustic startle magnitude (F 2,12 =2.82, n.s. ; Fig. 6a ). The drug, however, elicited a significant PPI reduction (treatment : F 2,12 =9.65, p<0.01 ; Fig. 6b ). Post-hoc analysis revealed that mice treated with 10 mg/kg IVM showed a significantly lower PPI than both the groups treated with vehicle (p<0.01) and 2.5 mg/kg IVM (p<0.05).
Novel object exploration/recognition
As shown in Fig. 7a , IVM decreased the duration of novel object exploration (F 2,18 =3.49, p=0.05). This effect was due to a significant difference between the IVM doses of 2.5 and 10 mg/kg (p<0.05). While the drug did not have any effect on the number of exploratory approaches directed towards the objects (F 2,18 =0.58, n.s. ; Fig. 7b ), it did affect the mean duration of each sniffing episode (F 2,19 =3.75, p<0.05 ; data not shown). Further scrutiny of this latter effect depended on a significant difference between the two doses of IVM (p<0.05), as well as by a statistical trend (p<0.10) between vehicle and 2.5 mg/kg IVM (Tukey). No difference in preference between the two objects was detected in any of the treatment groups. The P2X 4 receptor activator failed to affect the mnemonic encoding of novel objects, as revealed by the equivalence of the novel exploration index at 24 h after the first exposure (F 2,18 =0.82, n.s. ; Fig. 7c ). In line with the results from the open field, no significant differences were observed in locomotor activity between treatment groups (data not shown).
Behavioural effects of IVM in P2X 4 KO mice
To verify whether the observed behavioural effects of IVM were mediated by P2X 4 receptors, we tested the high dose (10 mg/kg i.p.) of this compound in P2X 4 KO mice across the main paradigms significantly affected by it. In the open field, IVM evoked a spectrum of responses similar to those observed in WT mice, including the lack of changes in overall distance (F 1,12 =0.04, n.s. ; Fig. 8a ), as well as significant reductions in time (F 1,13 =22.61, p<0.001 ; Fig. 8b ) and percent distance travelled in the centre quadrant (F 1,12 =54.76, p<0.001 ; Fig. 8c ).
In the elevated plus maze, IVM significantly increased the duration of time spent in the open arms (F 1,13 =6.04, p<0.05 ; Fig. 8d ) and reduced the time spent in the closed arms by P2X 4 KO mice (F 1,13 =14.49, p<0.01 ; Fig. 8e ). In addition, IVM-treated P2X 4 KO mice exhibited significant enhancements in the total number of arm entries (F 1,13 =11.43, p<0.01 ; Fig. 8f )] and head dips (F 1,13 =11.75, p<0.01 ; Fig. 8g ).
In contrast with the effects of IVM in WT mice, this drug significantly increased startle amplitude (F 1,11 =6.25, p<0.05 ; Fig. 8e ) but did not reduce %PPI (F 3,9 =1.30, n.s. ; Fig. 8f ). 
Discussion
The results of the present study document that acute administration of IVM resulted in a complex set of effects on the regulation of emotional, cognitive and perceptual functions. In particular, the drug exhibited a multifaceted, complex profile with regard to complementary aspects of anxiety-like responsiveness. IVM induced a highly heterogeneous array of behavioural responses across different anxiety-related tasks.
In a novel open field, mice treated with this drug displayed a dosedependent increase in thigmotaxis, which was not accompanied by any other significant variation in locomotor and exploratory parameters. While these results are generally associated with anxiogenic-like effects (Prut & Belzung, 2003) , this interpretation is in stark contrast to the finding that the 10 mg/kg (but not 2.5 mg/kg) dose of IVM exerted a marked reduction of anxiety-like behaviours in the elevated plus maze and marbleburying assays. The discrepancies among IVM-induced effects on anxiety-like responses are likely to reflect the differential impact of this drug on diverse aspects of anxiety-related and exploratory responses. Although the ethological construct underlying most paradigms for anxiety testing in rodents is based on the conflict between exploration and neophobia in response to different environmental cues, several studies have documented that each test captures different dimensions of anxiety-related responsiveness (Belzung & Le Pape, 1994 ; Carola et al. 2002 ; Ramos et al. 1997) .
Additionally, IVM increased depression-associated indices in both the tail suspension and forced swim tests and reduced sensorimotor gating in the PPI assay. These results suggest that IVM induced depression-like reactions (albeit at different doses) in response to acute, inescapable stressors. Both assays carry high predictive validity for depression and treatments that increase immobility duration are generally interpreted to worsen mood, particularly if, like IVM, they elicit no intrinsic hypolocomotion or sedation. Although previous reports indicated that very high doses of IVM induced signs of depression in animals (Basudde, 1989) , the increased immobility in these studies is unlikely to reflect the same phenomena, since they were elicited by the low IVM dose in the tail suspension and not associated by any sign of acute toxicity in this or other studies (Yardley et al. 2012) . Notably, we found divergent dose-response relations of IVM-induced depressive-like effects in the tailsuspension test (in which immobility was observed in response to the 2.5 mg/kg, but not 10 mg/kg, dose) and in the forced swim test (which resulted in immobility only at the dose of 10 mg/kg). The differences between these two results are currently unknown, but they may reflect different sensitivities of these two paradigms to the various neurotransmitter systems that regulate stress reactivity. Indeed, although both paradigms are based on the same ethological construct, based on the immobility caused by inescapable situations (Castagné et al. 2011) , they have been shown to respond differently to several pharmacological agents (Chatterjee et al. 2012) .
Another interesting finding of our studies was that, in WT mice, IVM induced a dose-dependent reduction in PPI, without affecting acoustic startle magnitude, signifying that this drug has an acute impact on sensorimotor gating and information processing. This finding is in line with previous reports (Davis et al. 1999) , which documented PPI deficits following long-term administration of IVM in drinking water to mice. These impairments are connected to a broad set of neuropsychiatric deficits, ranging from psychotic disorders to obsessivecompulsive disorder and attention-deficit hyperactivity disorder. In addition, pharmacological disruptors of PPI in rodents have been shown to elicit psychotomimetic effects in humans. Irrespective of these considerations, it is interesting to note that IVM-induced gating impairments did not overtly affect declarative mnemonic encoding, as revealed by the novel object recognition test. This observation tempers the possibility that the observed changes in PPI may have a repercussion on cognition and learning.
It is relevant to note that IVM did not elicit overt rewarding and/or aversive actions in the CPP test. As the rewarding effects of a drug are regarded as a necessary premise for abuse and dependence, these data strongly suggest that IVM does not significantly modify incentive behaviour. Given the biased design of our protocol (which was used to enhance the sensitivity of the test to the potential rewarding effects of IVM), the apparent lack of aversive effects remains inconclusive, as it may be masked by potential floor effects. Irrespective of this issue, the lack of inherent addictive potential of IVM is in line with the absence of clinical notes on its recreational consumption in humans and is particularly important in view of the recent finding that this drug reduces alcohol intake in mice, as measured in several models (Yardley et al. 2012) .
To our knowledge, few studies have been published on the behavioural effects of IVM in rodents. In line with our findings, previous work showed the lack of effects of this drug on general parameters of health and motor coordination in mice and rats (Davis et al. 1999 ; Nafstad et al. 1991) . Davis et al. (1999) found that prolonged administration of IVM in tap water elicited significant psychotropic effects in several murine strains, including an enhancement in motor and acoustic reactivity as well as an attenuation of gating, but that it did not alter spatial learning. Furthermore, i.p. injections of low IVM doses were found to exert rapid anxiolytic-like properties in the elevated plus maze and Vogel test in rats (de Spinosa et al. 2002) . Although these findings cannot be directly compared to our results, in view of differences in regimens of administration and species (or strains) tested, our study confirmed that IVM exerts psychotropic properties and induces a complex array of effects on emotional regulation.
The multi-faceted behavioural profile of IVM across the tests in this study is likely to reflect the involvement of multiple, divergent neurochemical targets of this drug, also in relation to the different sensitivity of each paradigm to different systems. In mammals, high-affinity binding sites for IVM have been characterized on GABA A (Huang & Casida, 1997) and P2X 4 receptors (Priel & Silberberg, 2004) .
Given the lack of available effective P2X 4 receptor antagonists, we tested the effects of P2X 4 KO mice to identify the specific contributions of this target to IVMinduced behavioural effects. The effects of IVM remained substantially unaltered in the open field and elevated plus maze, suggesting that P2X 4 receptors do not play a critical role in the modulation of anxiety-related responses in paradigms based on the conflict between approach and avoidance with regard to unprotected environments. Thus, it is likely that the apparently antithetical effects of IVM in the open field and elevated plus maze may reflect the impingement of other receptors. For example, the behavioural changes in the elevated plus maze are in line with the anxiolytic-like properties of GABA A receptor agonists (Davis et al. 1999) .
In contrast, IVM elicited significantly divergent effects in WT and P2X 4 KO mice with regard to startle and PPI. In particular, IVM enhanced the startle amplitude of P2X 4 KO mice, suggesting a role of these receptors in the regulation of acoustic startle response. Further research will be needed to fully understand the specific neurobiological underpinnings of the role of these targets in the modulation of startle.
In addition, we found that IVM did not induce any impairments of PPI in P2X 4 KO mice, suggesting that the deficits in sensorimotor gating caused by this drug were in fact mediated by P2X 4 receptor activation.
Although the tail-suspension effects of IVM were not tested in P2X 4 KO mice, the enhancement of tailsuspension immobility by IVM is also unlikely to strictly reflect the outcomes of GABA A activation, as this effect is dose-dependent and reflects a reduction in overall locomotor activity (Steru et al. 1987) . Given that tailsuspension and forced swim behaviours are poorly sensitive to the outcomes of GABA A receptor activation (Borsini & Meli, 1988 ; Steru et al. 1987) , it is possible that IVM-induced responses may reflect a more prominent influence by P2X 4 receptors. These results indicate that positive allosteric modulation of P2X 4 receptors may directly modulate emotional reactivity in response to acute stressors, possibly inducing anxiety-and depression-like responses. Complementary to this idea, previous studies suggest that the behavioural effects of some antidepressant agents may in fact be mediated by the blockade of P2X 4 receptors, (Sim & North, 2010 ; Toulme et al. 2010b ; for contrasting results see Nagata et al. 2009 ).
Recent evidence suggests that P2X 4 receptors may negatively interact with the effects of GABA A receptor activation (Jo et al. 2011) , providing a possible explanation for the contrasting outcomes observed across different tests. In particular, it is possible that P2X 4 receptor activation may induce aversive effects, which may contrast the rewarding properties of GABA A receptor activation. Thus, the simultaneous stimulation of both targets may reduce the addictive potential associated with GABA A receptor agonists.
The identification of novel pharmacological targets for behavioural regulation is a task of paramount importance, in consideration of the largely inadequate therapeutic armamentarium for neuropsychiatric conditions. The translational implications of our data afford a broader perspective on the behavioural effects of IVM. Further studies are necessary to qualify the nature of the potentially untoward effects documented by this study, such as the increase in depression-like responses and the sensorimotor gating deficits. Our results point to a role of P2X 4 receptors in the modulation of startle responsiveness, as well as sensorimotor gating. Future studies with selective antagonists or small interfering RNAs for P2X 4 receptors will be critical to ascertain the implication of the activation of these targets. Irrespective of these aspects, the lack of rewarding properties of IVM in the CPP paradigm, its anxiolytic-like properties in two complementary paradigms for anxiety-related behaviours and its ability to attenuate alcohol intake (Yardley et al. 2002) strongly suggest that IVM and its derivatives may be of great interest for the development of novel therapeutic avenues in neuropsychiatric therapy.
